all report title image
  • Published In : May 2024
  • Code : CMI6956
  • Pages :152
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Market Size and Trends

Global healthcare consumables market is estimated to be valued at USD 172.31 Bn in 2024 and is expected to reach USD 376.91 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.8% from 2024 to 2031.

Global Healthcare Consumables Market Key Factors

To learn more about this report, request a free sample copy

Global healthcare consumables market is expected to witness steady growth due to increasing geriatric population worldwide and rising incidence of chronic as well as infectious diseases. Growing demand for better healthcare services coupled with technological advancements in healthcare infrastructure and consumables can drive the market growth in the near future. Rising medical tourism and increased healthcare spending is also expected to drive the market growth.

Increasing Product Launches by Key Market Players

Increasing adoption of organic growth strategies such as product launches by key market players is expected to drive the market growth over the forecast period. For instance, in January 2023, Convatec, a global medical products and technologies company, announced the U.S. launch of ConvaFoam, a family of advanced foam dressings that is designed to address the needs of healthcare providers and their patients. ConvaFoam can be used on a spectrum of wound types at any stage of the wound journey, thus, making it the simple dressing choice for wound management and skin protection.

Increasing Inorganic Growth Strategies by Key Market players

Increasing adoption of inorganic growth strategies such as acquisition, in order to expand its product portfolio in the market, is expected to drive the market growth over the forecast period. For instance, in March 2022, Convatec Inc., a global medical products and technology company, announced that it had completed the acquisition of Triad Life Sciences Inc., a biotechnology company, The Triad team, current portfolio and product pipeline will now transition to Convatec’s Advanced Wound Care (AWC) business and be known as Convatec Advanced Tissue Technologies. The acquisition supports Convatec’s FISBE strategy (Focus-Innovate-Simplify-Build-Execute) by strengthening Convatec’s AWC position in the U.S. (Focus) and securing access to a complementary and innovative technology platform (Innovation) that enhances advanced wound management and patient outcomes.

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.